Stock Analiz

Akari Therapeutics Plc (AKTX) stock forecast and price target

Price $6.80 · data as of November 13, 2026

12-month price target

Average target$25.50
Upside / downside+275.0%
Analysts3
ConsensusNone
Low $19.50Average $25.50High $30.00

Gold marker: average target · white marker: today’s price ($6.80)

Analyst ratings

Strong buy 1Buy 2Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-9.05−113025.0%$0
Next fiscal year
ends December 31, 2027
$-8.65+4.4%$0
Next quarter
ends December 31, 2026
$-2.11—$0
Quarter after
ends March 31, 2027
$-2.09+0.0%$0

Consensus of the analysts covering Akari Therapeutics Plc, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Akari Therapeutics Plc stock price target?

The average 12-month target from 3 analysts is $25.50, 275.0% above the current price of $6.80 Targets range from $19.50 to $30.00.

Is Akari Therapeutics Plc a buy according to analysts?

The consensus rating is “None” (1 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Akari Therapeutics Plc expected to earn?

Analysts expect EPS of $-9.05 for the fiscal year ending December 31, 2026 and $-8.65 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.